arrow
返回

Antineoplastic Agents Targeting Sphingolipid Pathways

delete2020-05-22
delete21
delete
OA
AI
A
Alexander Kroll
H
Hwang Eui Cho
M
Min H. Kang *
DOI:10.3389/fonc.2020.00833delete
delete原文链接
delete分享
delete收藏
查看原文
摘要

摘要

En 中文
Emerging studies in the enigmatic area of bioactive lipids have made many exciting new discoveries in recent years. Once thought to play a strictly structural role in cellular function, it has since been determined that sphingolipids and their metabolites perform a vast variety of cellular functions beyond what was previously believed. Of utmost importance is their role in cellular signaling, for it is now well understood that select sphingolipids serve as bioactive molecules that play critical roles in both cancer cell death and survival, as well as other cellular responses such as chronic inflammation, protection from intestinal pathogens, and intrinsic protection from intestinal contents, each of which are associated with oncogenesis. Importantly, it has been demonstrated time and time again that many different tumors display dysregulation of sphingolipid metabolism, and the exact profile of said dysregulation has been proven to be useful in determining not only the presence of a tumor, but also the susceptibility to various chemotherapeutic drugs, as well as the metastasizing characteristics of the malignancies. Since these discoveries surfaced it has become apparent that the understanding of sphingolipid metabolism and profile will likely become of great importance in the clinic for both chemotherapy and diagnostics of cancer. The goal of this paper is to provide a comprehensive review of the current state of chemotherapeutic agents that target sphingolipid metabolism that are undergoing clinical trials. Additionally, we will formulate questions involving the use of sphingolipid metabolism as chemotherapeutic targets in need of further research.
Keyword:
sphingolipids
ceramides
sphingosine-1-phosphate
sphingomyelin
lipid biomarkers
AI总结

AI总结

对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

Frontiers in Oncology 封面图
Frontiers in Oncology
IF:
3.3
论文数:
3.5W
被引数:
9.5W

机构

Texas Tech University System 封面图
Texas Tech University System
学者数:
1.5W
论文数: 1.3W
被引数: 15
T
texas tech university health sciences center lubbock
学者数:
1.1K
论文数: 812
被引数: 0
引用论文

引用论文

Acid Ceramidase Upregulation in Prostate Cancer Cells Confers Resistance to Radiation: AC Inhibition, a Potential Radiosensitizer
err2009-03-01
err128
errOAAI
errMahdy, Ayman E. M.; Cheng, Joseph C.; Li, Jun; Elojeimy, Saeed; Meacham, William D.; Turner, Lorianne S.; Bai, Aiping; Gault, Christopher R.; McPherson, Alex S.; Garcia, Nicole; Beckham, Thomas H.; Saad, Antonio; Bielawska, Alicja; Bielawski, Jacek; Hannun, Yusuf A.; Keane, Thomas E.; Taha, Mohhammed I.; Hammouda, Hisham M.; Norris, James S.; Liu, Xiang
err分享
err收藏
Targeting (cellular) lysosomal acid ceramidase by B13: Design, synthesis and evaluation of novel DMG-B13 ester prodrugs
err2014-12-01
err33
errOAAI
errBai, Aiping; Szulc, Zdzislaw M.; Bielawski, Jacek; Pierce, Jason S.; Rembiesa, Barbara; Terzieva, Silva; Mao, Cungui; Xu, Ruijuan; Wu, Bill; Clarke, Christopher J.; Newcomb, Benjamin; Liu, Xiang; Norris, James; Hannun, Yusuf A.; Bielawska, Alicja
err分享
err收藏
Ceramide synthases and ceramide levels are increased in breast cancer tissue
err2009-03-11
err200
errOAAI
errSchiffmann, Susanne; Sandner, Jessica; Birod, Kerstin; Wobst, Ivonne; Angioni, Carlo; Ruckhaeberle, Eugen; Kaufmann, Manfred; Ackermann, Hanns; Loetsch, Joern; Schmidt, Helmut; Geisslinger, Gerd; Groesch, Sabine
err分享
err收藏
Mitochondrially targeted ceramide LCL-30 inhibits colorectal cancer in mice
err2007-11-20
err35
errOAAI
errDahm, F.; Bielawska, A.; Nocito, A.; Georgiev, P.; Szulc, Z. M.; Bielawski, J.; Jochum, W.; Dindo, D.; Hannun, Y. A.; Clavien, P-A
err分享
err收藏
Tricyclodecan-9-yl-Xanthogenate (D609) Mechanism of Actions: A Mini-Review of Literature
err2011-11-22
err89
errOAAI
errAdibhatla, Rao Muralikrishna; Hatcher, J. F.; Gusain, A.
err分享
err收藏
Functional inhibition of acid sphingomyelinase by Fluphenazine triggers hypoxia-specific tumor cell death
err2017-03-30
err29
errOAAI
errKlutzny, Saskia; Lesche, Ralf; Keck, Matthias; Kaulfuss, Stefan; Schlicker, Andreas; Christian, Sven; Sperl, Carolyn; Neuhaus, Roland; Mowat, Jeffrey; Steckel, Michael; Riefke, Bjoern; Prechtl, Stefan; Parczyk, Karsten; Steigemann, Patrick
err分享
err收藏
学者 查看更多内容